USPTO rejects pending claims on nebivolol patent as unpatentable
Saturday, September 06, 2008 11:00 IST New York
Forest Laboratories, Inc announced that an Office Action in the Reexamination of U S Patent No. 6,545,040 ('the '040 patent') was received from the U S Patent and Trademark Office ('USPTO') by Janssen Pharmaceutica N V
